Home

pin Elevator skal teva marketwatch Proportional Bidrag biord

TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.

TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE)  | Barron's
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's

TEVA — TradingView
TEVA — TradingView

Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid  crisis - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch

Teva shares hit 19-year low after opioid settlement, analyst downgrades |  Fierce Pharma
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma

A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd ( TEVA) Stock
A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd ( TEVA) Stock

Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% -  TheStreet
Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% - TheStreet

Teva Pharmaceuticals - Wikiwand
Teva Pharmaceuticals - Wikiwand

Teva backs full-year guidance despite Q3 sales miss
Teva backs full-year guidance despite Q3 sales miss

Teva Pharmaceuticals - Wikiwand
Teva Pharmaceuticals - Wikiwand

Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. |  Barron's
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's

Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's

European Commission suspects pharma group Teva broke antitrust rules
European Commission suspects pharma group Teva broke antitrust rules

Teva in talks to buy Allergan's generics unit - MarketWatch
Teva in talks to buy Allergan's generics unit - MarketWatch

Teva's CEO on Why the Drugmaker Is Confident Despite Covid-19 | Barron's
Teva's CEO on Why the Drugmaker Is Confident Despite Covid-19 | Barron's

Teva Stock Sees Another Big Buy From Chairman Sol Barer | Barron's
Teva Stock Sees Another Big Buy From Chairman Sol Barer | Barron's

Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ

Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch

Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's
Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's

Teva Pharmaceutical Industries - Updates, News, Events, Signals & Triggers
Teva Pharmaceutical Industries - Updates, News, Events, Signals & Triggers

Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ

How Warren Buffett Triggered Teva's Epic Short Squeeze - New York Shock  Exchange
How Warren Buffett Triggered Teva's Epic Short Squeeze - New York Shock Exchange

Is the new Teva x Ugg collection fashion-forward or just plain ugly? -  MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch

Teva beats first-quarter expectations but still has the same old problems -  MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch

Teva: Avoid (NYSE:TEVA) | Seeking Alpha
Teva: Avoid (NYSE:TEVA) | Seeking Alpha

What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking  Alpha
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha

TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE)  | Barron's
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's

Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) |  Seeking Alpha
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha